FIELD: medicine. SUBSTANCE: agent has synergistically acting components - nonapeptide DSIP having the following sequence of amino acids: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and glycine at mass ratio = (1:1)-(1:100), respectively. Agent is used by intranasal route at the dose 0.3-0.9 mg/day for 1-3 days for stress state treatment; at the dose 0.3-0.6 mg/day for 7-14 days for memory and attention improvement and mental working capacity increase; at the dose 0.3-3 mg/day for alcoholism treatment; at the dose 0.3-0.9 mg/day for 5-12 days for narcomania treatment and abstinent syndrome arresting. EFFECT: enhanced effectiveness of agent. 4 cl
Authors
Dates
1997-12-20—Published
1994-12-08—Filed